A policy case study of blood in Australia
- 30 November 2010
- journal article
- research article
- Published by Elsevier BV in Social Science & Medicine
- Vol. 71 (9), 1677-1682
- https://doi.org/10.1016/j.socscimed.2010.07.035
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Economic rationale for infection control in Australian hospitalsHealthcare infection, 2009
- International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?Health Economics, 2009
- Review of Australian health economic evaluation – 245 interventions: what can we say about cost effectiveness?Cost Effectiveness and Resource Allocation, 2008
- Effect of Healthcare-Acquired Infection on Length of Hospital Stay and CostInfection Control & Hospital Epidemiology, 2007
- Costs of Surgical Site Infections That Appear after Hospital DischargeEmerging Infectious Diseases, 2006
- Whither trial‐based economic evaluation for health care decision making?Health Economics, 2006
- Use of evidence in decision models: an appraisal of health technology assessments in the UK since 1997Journal of Health Services Research & Policy, 2005
- Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from bloodThe Lancet, 2004
- National Institute for Clinical Excellence and its value judgmentsBMJ, 2004
- Clinical and laboratory factors associated with platelet transfusion refractoriness: a case–control studyBritish Journal of Haematology, 1996